“The mean … who used esomeprazole was significantly increased … use of CC (mean AUC [0 to 12 h] increase, 39%; P 5 .004), whereas erlotinib exposure in patients who consumed CC … without a PPI proved to be clinically irrelevant (mean AUC [0 to 12 h] increase, 9%; P 5 .03).”